(Q53319848)
Statements
Oral physostigmine in Alzheimer's disease: effects on norepinephrine and vasopressin in cerebrospinal fluid and plasma. (English)
Peskind ER
Raskind MA
Wingerson D
Pascualy M
Thal L
Veith RC
Dorsa DM
Bodenheimer S
1 October 1995
38
8
532-538